ORKA Earnings Date: Nov 11, 2026 (Estimated) — Oruka Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is ORKA's next earnings date?
Oruka Therapeutics, Inc. (ORKA) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.60.
How did ORKA do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Oruka Therapeutics, Inc. posted EPS of -$0.55 versus the -$0.51 estimate, a miss of 10.0%. Revenue was $0. The stock's 1-day post-earnings move was +6.4%.
How much does ORKA stock move after earnings?
ORKA beat EPS estimates in 3 of its last 7 reported quarters. Over the last 7 reports the stock moved an average of 7.1% (up or down) in the day after earnings.
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.51 | -0.55 | -10.00% | $0 | ❌ Miss | +6.40% | +12.37% | -4.56% |
| 2026-05-13 | Q1 2026 | -0.53 | -0.48 | +9.43% | $0 | ✅ Beat | +1.14% | -3.97% | +10.62% |
| 2026-03-12 | Q4 2025 | -0.61 | -0.45 | +26.23% | $0 | ✅ Beat | +25.04% | +21.35% | +91.87% |
| 2025-11-12 | Q3 2025 | -0.54 | -0.55 | -1.85% | $0 | ❌ Miss | -6.78% | -0.14% | +6.64% |
| 2025-08-11 | Q2 2025 | -0.45 | -0.46 | -2.22% | $0 | ❌ Miss | -0.31% | +17.42% | +22.61% |
| 2025-03-06 | Q4 2024 | -0.98 | -0.49 | +50.00% | $0 | ✅ Beat | +3.87% | +10.63% | -22.24% |
| 2024-11-13 | Q3 2024 | -0.40 | -1.46 | -265.00% | $0 | ❌ Miss | -6.43% | -13.45% | -14.46% |
| 2022-12-30 | — | -0.98 | — | — | — | — | — | — |
Showing last 8 quarters.